For more information, please contact:

Heather Collins or the Core staff at The Smilow Center for Translational Resarch - First Floor, SCTR 1-173
Tel) 215-898-4368 | Fax) 215-898-2178 | E-mail: hwc@pennmedicine.upenn.edu

Michael Rickels, MD, MS

Michael R. Rickels, M.D., M.S.

Dr. Rickels is Associate Professor of Medicine in the Division of Endocrinology, Diabetes & Metabolism and Director of the Penn Diabetes Research Center Radioimmunoassay & Biomarkers Core. Dr. Rickels has extensive training and expertise in clinical and translational diabetes research, and also serves as Director of the Translational Research Program of IDOM, and as Associate Director of the CTSA-sponsored Center for Human Phenomic Science (CHPS) of the Institute for Translational Medicine and Therapeutics (ITMAT) at Penn. He has extensive experience with RIAs, ELISAs, HPLC, GC-MS, autoanalyzer and colorimetric biochemical assays of islet cell, incretin, and counterregulatory hormones, stable glucose isotopes, metabolites and inflammatory biomarkers in humans and non-human primates, and is responsible for the strategic direction and scientific oversight of the RIA/Biomarkers Core.


Heather W. Collins, PhD

Heather W. Collins, Ph.D.

Dr. Collins is the Technical Director of the Penn Diabetes Research Center Radioimmunoassay & Biomarkers Core. Dr. Collins has over 25 years of laboratory experience and expertise in the development and application of novel immunoassay techniques. Dr. Collins handles the day-to-day operation of the RIA/Biomarkers Core with the support of Research Specialists Ms. Xiaolan Li and Ms. Brenda Spurgeon.


Xiaolin Li

Xiaolan Li

Ms. Li is a Research Specialist in the Penn Diabetes Research Center Radioimmunoassay & Biomarkers Core. Ms. Li has over 20 years of laboratory experience in the performance of RIAs and ELISAs.


Brenda Spurgeon

Brenda J. Spurgeon

Ms. Spurgeon is a Research Specialists in the Penn Diabetes Research Center Radioimmunoassay & Biomarkers Core. Ms. Spurgeon has over 20 years of laboratory experience in the performance of RIAs and ELISAs.